PREDICTIVE VALUE OF ULTRASOUND FEATURES FOR HER2 STATUS IN PRIMARY BREAST CANCER
Main Article Content
Abstract
Objective: To evaluate the correlation and predictive value of ultrasound features for HER2 status in primary breast cancer lesions. Subjects and Methods: A retrospective study analyzing 145 patients with 152 primary breast cancer lesions, all of which had confirmed HER2 status by immunohistochemistry. Ultrasound features were analyzed using univariate and multivariate logistic regression to identify independent predictive factors. The performance of the final prediction model was assessed using receiver operating characteristic (ROC) curve analysis. Results: Among 152 breast cancer lesions, 39 cases (25.7%) were HER2-positive (+) and 113 cases (74.3%) were HER2-negative (−). Multivariate logistic regression analysis showed that indistinct margins (OR = 10.72; p = 0.049) and microcalcifications (OR = 3.89; p = 0.002) were statistically significant independent predictors of HER2 positivity. The predictive model combining these two features demonstrated good diagnostic performance, with an area under the ROC curve (AUC) of 0.775 (95% CI: 0.69–0.86; p < 0.001). Conclusion: A predictive model combining margin characteristics and the presence of microcalcifications has value in early prediction of HER2 status, providing effective support for clinical decision-making.
Article Details
Keywords
Breast cancer, HER2, breast ultrasound, logistic regression, ROC curve.
References
2. Brown J. All About HER2 Status in Breast Cancer. Breast Cancer Research Foundation. March 28, 2025. Accessed June 2, 2025. https://www.bcrf. org/about-breast-cancer/her2-status-breast-cancer/
3. Portnow LH, Kochkodan-Self JM, Maduram A, et al. Multimodality Imaging Review of HER2-positive Breast Cancer and Response to Neoadjuvant Chemotherapy. RadioGraphics. 2023;43(2):e220103. doi:10.1148/rg.220103
4. Wu T, Li J, Wang D, et al. Identification of a correlation between the sonographic appearance and molecular subtype of invasive breast cancer: A review of 311 cases. Clin Imaging. 2019;53: 179-185. doi:10.1016/j.clinimag.2018. 10.020
5. Çelebi F, Pilancı KN, Ordu Ç, et al. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer. Diagn Interv Radiol Ank Turk. 2015;21(6): 448-453. doi:10.5152/dir.2015. 14515
6. Rashmi S, Kamala S, Murthy SS, Kotha S, Rao YS, Chaudhary KV. Predicting the molecular subtype of breast cancer based on mammography and ultrasound findings. Indian J Radiol Imaging. 2018;28(3):354-361. doi:10. 4103/ijri.IJRI_78_18
7. Liao N, Zhang G chun, Liu Y hui, et al. HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component. Pathol Res Pract. 2011;207(1):1-7. doi:10.1016/ j.prp.2010.08.005
8. Park YJ, Youk JH, Son EJ, Gweon HM, Kim JA. Comparison of hormonal receptor and HER2 status between ultrasound-guided 14-gauge core needle biopsy and surgery in breast cancer patients. Ultrasonography. 2014;33(3):206-215. doi:10.14366/usg.14014
9. Khalaf LMR, Herdan RA. Role of ultrasound in predicting the molecular subtypes of invasive breast ductal carcinoma. Egypt J Radiol Nucl Med. 2020;51(1):138.doi:10.1186/s43055-020-00240-z
10. Dai X, Li T, Bai Z, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015;5(10):2929-2943.